Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes.

Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W, Schoch C.

Genes Chromosomes Cancer. 2005 Jun;43(2):113-27.

PMID:
15751046
2.

Immunological definition of acute promyelocytic leukemia (FAB M3): a study of 39 cases.

De Rossi G, Avvisati G, Coluzzi S, Fenu S, LoCoco F, Lopez M, Nanni M, Pasqualetti D, Mandelli F.

Eur J Haematol. 1990 Sep;45(3):168-71.

PMID:
1977611
3.

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.

Allford S, Grimwade D, Langabeer S, Duprez E, Saurin A, Chatters S, Walker H, Roberts P, Rogers J, Bain B, Patterson K, McKernan A, Freemont P, Solomon E, Burnett A, Goldstone A, Linch D.

Br J Haematol. 1999 Apr;105(1):198-207.

PMID:
10233384
4.

The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes.

Albano F, Mestice A, Pannunzio A, Lanza F, Martino B, Pastore D, Ferrara F, Carluccio P, Nobile F, Castoldi G, Liso V, Specchia G.

Haematologica. 2006 Mar;91(3):311-6.

5.

Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with flt3 mutational status.

Marasca R, Maffei R, Zucchini P, Castelli I, Saviola A, Martinelli S, Ferrari A, Fontana M, Ravanetti S, Torelli G.

Leukemia. 2006 Jan;20(1):103-14.

PMID:
16270043
6.

Detailed analysis of FLT3 expression levels in acute myeloid leukemia.

Kuchenbauer F, Kern W, Schoch C, Kohlmann A, Hiddemann W, Haferlach T, Schnittger S.

Haematologica. 2005 Dec;90(12):1617-25.

7.

Cytogenetic and clinical studies in acute promyelocytic leukemia (M3) and cytologic M3 variant (M3V).

Montaldi A, Dragone P, Scala D, D'Emilio A, Battista R, Stella M, Dini E.

Cancer Genet Cytogenet. 1989 Feb;37(2):263-8.

PMID:
2702625
8.

Expression of T-lineage-affiliated transcripts and TCR rearrangements in acute promyelocytic leukemia: implications for the cellular target of t(15;17).

Chapiro E, Delabesse E, Asnafi V, Millien C, Davi F, Nugent E, Beldjord K, Haferlach T, Grimwade D, Macintyre EA.

Blood. 2006 Nov 15;108(10):3484-93.

10.

Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants.

Neame PB, Soamboonsrup P, Leber B, Carter RF, Sunisloe L, Patterson W, Orzel A, Bates S, McBride JA.

Am J Hematol. 1997 Nov;56(3):131-42.

11.

Rearrangements of the RAR-alpha gene in acute promyelocytic leukaemia: correlations with morphology and immunophenotype.

Lo Coco F, Avvisati G, Diverio D, Biondi A, Pandolfi PP, Alcalay M, De Rossi G, Petti MC, Cantù-Rajnoldi A, Pasqualetti D, et al.

Br J Haematol. 1991 Aug;78(4):494-9.

PMID:
1911341
12.

Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events.

Debernardi S, Lillington DM, Chaplin T, Tomlinson S, Amess J, Rohatiner A, Lister TA, Young BD.

Genes Chromosomes Cancer. 2003 Jun;37(2):149-58.

PMID:
12696063
13.

Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.

Larson RA, Le Beau MM.

Chem Biol Interact. 2005 May 30;153-154:187-95.

PMID:
15935816
14.

Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant.

Piedras J, López-Karpovitch X, Cárdenas R.

Cytometry. 1998 Aug 1;32(4):286-90.

PMID:
9701397
15.

Expression of cell-surface antigens in acute promyelocytic leukaemia.

Paietta E.

Best Pract Res Clin Haematol. 2003 Sep;16(3):369-85. Review.

PMID:
12935957
16.

Molecular characterization of acute leukemias by use of microarray technology.

Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, Haferlach T.

Genes Chromosomes Cancer. 2003 Aug;37(4):396-405.

PMID:
12800151
17.

Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.

Lin P, Hao S, Medeiros LJ, Estey EH, Pierce SA, Wang X, Glassman AB, Bueso-Ramos C, Huh YO.

Am J Clin Pathol. 2004 Mar;121(3):402-7.

PMID:
15023045
18.

A unique case of t(15;17) acute promyelocytic leukaemia (M3) developing into acute myeloblastic leukaemia (M1) with t(7;21) at relapse.

Jubashi T, Nagai K, Miyazaki Y, Nakamura H, Matsuo T, Kuriyama K, Tomonaga M.

Br J Haematol. 1993 Apr;83(4):665-8.

PMID:
8518183
19.

Translocation (15;17) and trisomy 21 in the microgranular variant of acute promyelocytic leukemia.

Spell DW, Velagaleti GV, Jones DV, Velasquez WS.

Cancer Genet Cytogenet. 2002 Jan 1;132(1):74-6.

PMID:
11801315
20.

Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling.

Vey N, Mozziconacci MJ, Groulet-Martinec A, Debono S, Finetti P, Carbuccia N, Beillard E, Devilard E, Arnoulet C, Coso D, Sainty D, Xerri L, Stoppa AM, Lafage-Pochitaloff M, Nguyen C, Houlgatte R, Blaise D, Maraninchi D, Birg F, Birnbaum D, Bertucci F.

Oncogene. 2004 Dec 16;23(58):9381-91.

PMID:
15543237

Supplemental Content

Support Center